Schrodinger, Inc. Debt to Equity Ratio 2019-2024 | SDGR
Current and historical debt to equity ratio values for Schrodinger, Inc. (SDGR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Schrodinger, Inc. debt/equity for the three months ending September 30, 2024 was 0.00.
| Schrodinger, Inc. Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-09-30 | $0.22B | $0.45B | 0.49 |
| 2024-06-30 | $0.21B | $0.47B | 0.45 |
| 2024-03-31 | $0.22B | $0.51B | 0.44 |
| 2023-12-31 | $0.25B | $0.55B | 0.46 |
| 2023-09-30 | $0.23B | $0.56B | 0.41 |
| 2023-06-30 | $0.23B | $0.61B | 0.38 |
| 2023-03-31 | $0.25B | $0.59B | 0.42 |
| 2022-12-31 | $0.24B | $0.45B | 0.54 |
| 2022-09-30 | $0.20B | $0.46B | 0.43 |
| 2022-06-30 | $0.20B | $0.49B | 0.40 |
| 2022-03-31 | $0.19B | $0.53B | 0.36 |
| 2021-12-31 | $0.20B | $0.56B | 0.36 |
| 2021-09-30 | $0.18B | $0.58B | 0.32 |
| 2021-06-30 | $0.11B | $0.61B | 0.18 |
| 2021-03-31 | $0.11B | $0.63B | 0.18 |
| 2020-12-31 | $0.12B | $0.62B | 0.20 |
| 2020-09-30 | $0.05B | $0.63B | 0.08 |
| 2020-06-30 | $0.05B | $0.30B | 0.18 |
| 2020-03-31 | $0.05B | $0.30B | 0.18 |
| 2019-12-31 | $0.06B | $0.10B | 0.58 |
| 2019-09-30 | $0.00B | $0.00B | 0.00 |
| 2019-06-30 | $0.00B | $0.00B | 0.00 |
| 2019-03-31 | $0.00B | $0.00B | 0.00 |
| 2018-12-31 | $0.03B | $0.09B | 0.34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||